U.S. Supreme Court rejects Acorda appeal in MS drug patent fight

The U.S. Supreme Court on Monday declined to hear Acorda Therapeutics Inc's appeal of a lower court ruling that allowed generic versions of its multiple sclerosis treatment Ampyra and caused the drug's sales to plummet.

from Reuters: Health News https://ift.tt/2AOJZ99